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Fibrin is the native provisional protein matrix that is formed from its precursor, fibrinogen, as part of the enzymatic cascade responsible for blood clotting. Along with platelet adhesion and the formation of a platelet plug, in vivo formation of the polymeric fibrin network is the key event in the arrest of bleeding at the site of injury (hemostasis). [1, 2] The fibrin gel serves as glue for activated platelets thereby reinforcing the platelet plug and ceasing bleeding. However, in cases of acute hemorrhage, these processes are insufficient and hemostatic technologies are used to aid the natural clotting cascade, reduce blood loss, and increase survival rates of patients suffering from traumatic injuries. Current technologies include topical dressings, such as polysaccharide-based agents and exothermic zeolites, recombinant clotting factors, and synthetic derived adhesives, e.g., poly(cyanoacrylates) and in situ forming synthetic tissue sealants. [3] [4] [5] Despite the growing number of available hemostatic agents, uncontrolled bleeding is still the leading cause of death due to trauma in battlefield and civilian settings. [6, 7] A C C E P T E D M A N U S C R I P T
In particular, treatment of non-compressible, internal injuries remains a major challenge. Cessation of internal bleeding is typically achieved by intravenous administration of antifibrinolytics and blood products, e.g., coagulation factors and allogeneic platelets. [5, 8] More recently, synthetic-derived coagulation systems and, in particular, synthetic platelet substitutes, have been investigated as promising alternatives. [8] [9] [10] Synthetically derived hemostatic particles have many advantages as compared to blood-based transfusion products, since they could be more affordable, unlimited in supply, and easier in handling and storage. Most efforts have been focused on the development of surface-functionalized particles displaying plateletbinding motifs or platelet-cell surface adhesion motifs to facilitate platelet clustering and adhesion to the wound site. [9, 11] The chemistry as well as the physical properties of these systems, such as mechanical properties, particle size and shape, are very diverse which reflects the complexity of the development of "artificial platelets". Examples for these constructs are fibrinogencoated microcapsules, [12] peptide-decorated liposomes, [13] nanoparticles consisting of a biodegradable copolymer core of poly(lactic-co-glycolic acid)/poly-(L)-lysine and poly(ethylene glycol) arms [14, 15] , and discoidal shaped poly(allylamine hydrochloride)/bovine serum albumin layer-by-layer capsules [16] . In an alternative approach, Chan et al. developed a hemostatic polymer which induces hemostasis by cross-linking the fibrin matrix within clots. [17] These polymers mimic the function of the transglutaminase factor XIII and, in addition, bind specifically to fibrin monomers resulting in a hybrid polymer network with enhanced resistance to enzymatic degradation.
In our recent studies, we focused on the design of platelet-like particles (PLPs) which are able to recapitulate vital platelet functions that include binding, stabilization, and enhancement of fibrin clot formation under physiological flow. [18] For this purpose, micron-sized, ultralow cross-linked (ULC) poly(N-isopropylacrylamide-coacrylic acid) (pNiPAm-co-AAc) microgels of unique deformability [19] were functionalized with variable domain-like recognition motifs (sdFv) [20] exhibiting high selectivity and affinity for nascent fibrin protofibrils but minimal binding to fibrinogen. These particles mimic the ability of natural platelets [21] to specifically bind to fibrin fibers and deform within the fibrin mesh to increase the number of microgel-fibrin binding events. These studies demonstrated that PLPs augment fibrin clotting, increase fibrin fiber density, and induce clot retraction in vitro similarly to natural platelets. The large network flexibility of PLPs was found to play a key role for complete clot collapse. Moreover, the purely synthetic particles achieve decreased bleeding times and blood loss in vivo, illustrating the utility of PLPs for use as synthetic hemostatic agents.
Herein, we demonstrate that PLPs can be designed from soft particle types other than ULC pNiPAm microgels. We used flexible self-cross-linked microgels based on the polymer poly(ethylene glycol) (PEG) to develop platelet-mimicking particles (PEG-PLPs). PEG polymers are generally considered to be biocompatible, low-toxic and bioinert and show minimal nonspecific protein binding. [22] Figure 1a and b display the constructs used for this study and their proposed interaction with nascent fibrin fibers. The particles are polymerized from oligo ethylene glycol methacrylate (OEGMA) and methacrylic acid in the absence of a cross-linking agent to form
negatively charged, self-cross-linked PEG side-chain microgel particles (scPEG µgels). In our recent study we showed that scPEG µgels deform to a much greater extent than particles cross-linked with poly(ethylene glycol) diacrylate (PEG-DA). [23] Although scPEG µgels do not exhibit the same degree of network deformability as ULC pNiPAm microgels, fibrin-PEG-PLPs were hypothesized to still recapitulate important features of natural platelets. Therefore, scPEG µgels could be a good alternative to the ULC pNiPAm microgels that were initially exploited as platelet "body" for PLPs. [18] Conjugation of sdFv units to the polymer network was realized via covalent coupling to the carboxylate groups of the microgels. The goal of our investigation is to demonstrate the ability of PEG-based, fibrin-specific µgels to target and enhance fibrin clot formation in vitro in a fashion that is similar to the results reported in Ref. [18] . Furthermore we wish to explore differences of the physical properties between native fibrin and microgel/fibrin composites with regards to the mechanical stiffness as well as the permeability for the solvent and smaller biomolecules. Finally, we study the degradability of microgel-reinforced fibrin gels in vitro to analyze their stability against enzymatic hydrolysis as compared to native fibrin networks.
Experimental Materials
Chemicals were purchased from Sigma-Aldrich unless otherwise specified.
Olig(ethylene glycol) methyl ether methacrylate (Mn= 300, OEGMA300) was passed 
Particle synthesis
Self-cross-linked PEG-sidechain microgels were synthesized via surfactant-free precipitation polymerization in a 250 mL three-necked round bottom flask equipped with a reflux condenser, N2 inlet, thermometer, and magnetic stirrer. OEGMA300 hours at 80 °C under a N2 blanket. After completion, the reaction solution was cooled to room temperature using an ice bath and filtered through glass wool to remove traces of coagulum. The final microgels were purified by dialysis (molecular weight cut off 12-14 kDa) against DI H2O for two weeks and were lyophilized before use. The particle yield was ~80 % by mass.
Protein-conjugation to microgels
Fibrin-speficic sdFv (H6) and a random, non-binding clone (S11) were previously identified through phage-display biopanning. Production and characterization of sdFvs were performed as described in Ref. [18] The antibody fragments were conjugated to the carboxylate groups of the scPEG µgel using standard EDC/sulfo-NHS chemistry.
Briefly, carboxylate groups on microgels were activated with 25 mM EDC and 37.5 mM sulfo-NHS in 0.1 M MES buffer, pH 5.5 for 20 minutes using a microgel concentration of 5 mg/mL. Microgels were centrifuged and the pelleted particles were 
Fibrin gel preparation
Thrombin-initiated fibrin polymerization was performed at room temperature either on cleaned glass substrates (CLSM and AFM studies) or inside of a plastic capillary tube (Globe Scientific, Inc., I.D. = 0.75 mm, perfusion and fibrin degradation studies).
Purified human fibrinogen, microgel particles, and human α-thrombin were mixed in 25 mM HEPES/150 mM NaCl/5 mM CaCl2, pH 7.4 to initiate clot formation with final working concentrations of 5 mg/mL fibrinogen, 0.75 U/mL thrombin, and 0.75 mg/mL particles (control fibrin clots did not contain particles). The clots were allowed to polymerize for at least 1 h prior to experiments. Fibrin gels for CLSM studies were polymerized between a glass slide and a coverslip. To render fibrin clots fluorescent, labeled fibrinogen (AlexaFluor 488 conjugate, Molecular Probes, Inc.) was added to the mixture at a molar ratio of 1:50 labeled:unlabeled fibrinogen.
Confocal laser scanning microscopy (CLSM) of fibrin gels
Clots were imaged using a Zeiss LSM 510 Confocal Microscope using a 63x/1.4 NA oil DIC M27 objective. An Ar + laser at 488 nm and a HeNe laser at 543 nm were used for excitation of AlexaFluor 488 labeled fibrinogen and rhodamine labeled particles, respectively. The pinhole diameter was set to 1 airy unit and a resolution of 512 x 512 pixels for 8-bit images was chosen.
AFM force spectroscopy of fibrin gels
Fibrin clots were polymerized on glass coverslips for 30-45 minutes and then overlaid with 30 µL of either buffer solution or dispersion with 0.75 mg/mL PEG-PLPs or S11-scPEG µgels. The gels were incubated overnight in a humid environment. AFM nanoindentaion experiments were performed on a MFP-3D AFM (Asylum Research, Santa Barbara, CA) using a silicon nitride SPM sensor with a cantilever spring constant of 0.08 N m 1 and a 3.5 µm SiO2 particle attached to it (NanoAndMore USA).
The fibrin clots and colloidal probe were fully immersed in buffer solution. The inverse optical laser sensitivity (InvOLS) and spring constant of the AFM probe were calibrated by a combination of single force curves on a stiff glass substrate and thermal spectra using methods in the MFP-3D software. The AFM was operated in contact mode and force maps with scan sizes of 40 µm x 40 µm or 80 µm x 80 µm were collected as a 24 x 25 array of force curves with a trigger point set to 1.0 V. The stiffness of different points of the gels was determined by fitting the force-deformation curves to the Hertz model. In case of spherical indenter geometry, the Hertz model is described by
where F is the force, Rc is the radius of the colloidal probe, ν is the Poisson ratio, E is the elastic modulus, and δ is the deformation of the sample. Mean elastic moduli of different fibrin clots were calculated from force-indentation curves of at least 3 force maps for each construct.
Fibrin gel perfusion experiments
To measure the hydraulic permeability of the fibrin/microgel hybrid materials the gels were polymerized in transparent plastic tubes that are used as permeation chambers ( Figure S1a ). After polymerization, the fibrin gels were cut to a length ranging between 1 to 1.5 cm and connected to a reservoir containing 25mM HEPES/150 mM NaCl, pH 7.4 buffer solution. The buffer was perfused by gravity through the fibrin gel at different pressure gradients and the volumetric flow rate was calculated by tracking the air/buffer interface in the plastic tubing that has been connected to the end of the permeation chamber. Thereby, the pressure gradient was adjusted by the liquid height of the reservoir. The volumetric flow rate was measured at 5 different pressure gradients for 5 min ( Figure S1b ) and repeated 3 times for each condition. To visualize the flow through the clot and identify possible gel ruptures and detachments, the percolating buffer was supplemented with 0.02 mg/mL methylene blue. The permeability was calculated from Darcy´s law which is given by
where Q is the volumetric flow, k is the Darcy constant, i.e., the permeability constant, µ is the liquid viscosity, ΔP is the pressure gradient across the clot, and A and L are the cross-sectional area and the length of the cylindrical clot, respectively.
To study the porosity of the fibrin clots for biomolecules the diffusional transport of 4 proteins with molecular weights ranging from 12 000 to 340 000 g/mol was In a separate experiment, transport of β-D-glucosidase with a concentration of 0.5 mg/mL (Glcase, Mw ~ 135 000 g/mol) was analyzed. The collected solution was tested for Glcase by using the quantitative CBQCA assay.
Clot degradation experiments
Fibrin clots formed in plastic capillary tubes were subjected to enzymatic degradation using human plasmin. Tubes were attached to a reservoir filled with 0.02 mg/mL plasmin and the volumetric flow rate through the clots was measured at certain time 
Statistical analysis
All statistical analyses were performed with Prism software program (GraphPad, San Diego CA). Data was analyzed using a one-way analysis of variance (ANOVA) with a
Tukey's posthoc test at a 95% confidence interval.
Results and Discussion

Preparation of fibrin-specific PEG-PLPs
For this investigation, rhodamine-labeled self-cross-linked microgels carrying PEG side-chains (scPEG µgels) and having a hydrodynamic diameter of 680 nm were prepared under cross-linker-free reaction conditions. Recently, we could show that it is possible to exploit chain transfer reactions originating from the oligo ethylene glycol side chains to create stable microgel particles with higher network flexibility than microgels containing a cross-linking monomer. [23] For example, when deposited on an amine-functionalized glass substrate, hydrated scPEG µgels spread with a diameter of 1031 ±107 nm but a small height of 106 ±27 nm (Figure 1c ). Compared to PEG-DA cross-linked microgels, scPEG µgels have a diameter to height ratio that is ~ 3 times larger than that of cross-linked particles. [23] Additionally, the elastic modulus of scPEG µgels were found to be <100 kPa and significantly smaller than the value found for cross-linked particles. [23] The soft
character of pNiPAm-based PLPs has been demonstrated to be essential to enable multiple binding to fibrin, to form local areas with high fiber density, and finally to induce overall clot retraction. [18] By analogy to our previous study, scPEG µgels were rendered fibrin-specific by peptide conjugation of sdFvs that show high affinity for nascent fibrin fibers but minimal binding to the soluble abundant precursor fibrinogen (H6). Particles carrying non-binding antibody fragments (S11) were used as control particles in addition to non-functionalized scPEG µgels. The recognition motifs have been identified by phage display [24] and were thoroughly characterized in terms of molecular weight and binding constants in Ref. [18] . Conjugation of peptides only slightly decreased the mean size and porosity of the particles as shown by tunable resistive pulse analysis ( Figure S2 ). Thus, we can make the reasonable assumption that the mechanical properties, i.e., the deformability, of these particles are not altered upon chemoligation of sdFvs.
Structural investigation of fibrin clots in presence of PEG-PLPs
To investigate the interaction of sdFv-conjugated scPEG µgels with fibrin, the formation of a fibrin clot was initiated by thrombin in presence of H6-, S11-or nonfunctionalized particles. Confocal microscopy images of these fibrin gels are shown in Figure 2a -d. The images were taken 2 or 24 h post-polymerization.
Supplementation of the fibrinogen solution with fibrin-specific PEG-PLPs resulted in
highly heterogeneous fibrin network structures with local spots of high fiber density
( Figure 2c ). It is important to note that these dense regions are found to be strongly correlated with areas of high particle number density. The confocal images suggest
that interactions between nascent fibrin and particles result in the local coagulation of the PEG-PLPs. On the other hand, the presence of non-binding S11-scPEG µgels (Figure 2b) does not significantly modify the fibrin network structure at the particle concentrations used, since no differences to the native fibrin clot are discerned ( Figure   2a ). However, clots formed in the presence of unmodified particles were found to consist of a slightly more porous network compared to native fibrin (Figure 2d ). 
Mechanics of fibrin clots in presence of microgels
To gain information on the network mechanical properties of the fibrin clots on the micrometer scale, AFM nanoindentation was employed in-liquid to generate elastic (E) modulus maps across the fibrin gels. To avoid any damage of the soft fibrin matrix, force-deformation curves were obtained using a soft cantilever with a colloidal probe attached to it. For these experiments, functionalized particles were added shortly after initiation of fibrin polymerization (30 min) to prevent binding and accumulation of scPEG µgels on the glass surface on which fibrin gels were formed. In this way, a more homogenous particle distribution throughout the fibrin clot, and, in particular, on the fibrin surface was guaranteed.
E-modulus maps of native fibrin and of fibrin clots containing PEG-PLPs and S11-scPEG µgels, respectively, are shown in Figure 3 . Native fibrin clots formed from PLPs show large gradients of elastic moduli ranging from 700 to 4800 Pa reflecting the highly heterogeneous network structure observed for these composites (Figure 3c ).
The average Young´s modulus of these particle-enriched fibrin clots is calculated as 1770 ±720 Pa, which is 4 times larger than the value found for the control (fibrin only, p <0.01). For comparison, clotting studies with platelet-poor and platelet-rich plasma have demonstrated that platelets enhance the clot stiffness by a factor of ~10. [21, 27] Thus, by analogy to platelets, binding of PEG-PLPs leads to reinforced fibrin networks of higher stiffness and enhanced stability against mechanical disintegration. Further studies suggest that the presence of non-binding S11-scPEG µgels show the tendency to increase the mechanical properties of fibrin clots as well, although the overall fibrin network morphology remains unchanged (Figure 2b and Figure 3c ); for these constructs an average elastic modulus of 960 ±130 Pa was found.However, this observation is not surprising, since the microgels exhibit larger Young´s moduli than fibrin and serve as space filling material for the pores within the fibrin network, resulting in an overall stiffer and denser hybrid material.
Network permeability of fibrin clots
In addition to its role in mechanics, the fibrin network structure determines the fluid flow and solute transport into and out of a clot. To analyze the fluid flow, the hydraulic permeability of fibrin clots was quantified from Darcy´s law by analyzing the liquid flow rate through the clots at varying pressure gradients across the fibrin gels. Experiments with control fibrin gels gave comparable results to those reported previously. [28, 29] The permeability of fibrin clots polymerized from a solution of fibrinogen and PEG-PLPs is decreased about 3 times (Figure 4 a) . Incorporation of non-binding S11-scPEG µgels into a fibrin clot also decreases the exchange rate of fluid. This observation is in accordance with the increased elastic moduli observed for particle-enriched fibrin gels and is explained by the microgels acting as space fillers for the pores within the fibrin mesh. The permeability data suggest that the mechanical reinforcement of the fibrin mesh through incorporation of the PEG-PLPs or S11-scPEG µgels into its pores is the main cause for the reduced permeability whereas the local PEG-PLP-induced fibrin collapse only contributes to a smaller extent. .
It is important to mention that scPEG µgels carrying no sdFvs at their periphery have an opposite effect on the network permeability ( Figure 4b ). Thereby, a linear relation is found between the particle concentration and Darcy constant; larger particle concentrations resulted in increased permeability (Figure 4b ). This result is in accordance with the coarser fiber structure found in fibrin networks formed in presence of plain (unmodified) scPEG µgels. PEG is known to act as possible precipitant for proteins, including fibrinogen, which makes it a highly useful adjuvant for protein crystallization. [30] [31] [32] The origin of PEG induced precipitation might be explained by theories of attractive depletion and excluded volume, however, its
is not yet fully understood. [32, 33] Notably, the effectiveness of PEG in reducing the solubility of proteins increases with increasing size of the PEG chain and it was found that larger proteins, such as fibrinogen, tend to precipitate at lower PEG concentrations than smaller proteins. [31] Moreover, Sim et al. demonstrated that branched PEG molecules act as protein precipitants, although to lower efficiency than the linear homologues of equivalent molecular weights. [34] From these studies, we can conclude that in analogy to linear PEG polymers, scPEG µgels are excluded from the fibrinogen surface and induce protein self-association as the microgel concentration is increased. We found that thrombin-initiated polymerization of fibrinogen in presence of scPEG µgels with concentrations ≥2 mg/mL results in the formation of fibrin networks consisting of a coarser structure and thicker fibers as compared to the control (fibrin only) ( Figure S3 ). Moreover, these structures are similar to fibrin clots formed in presence of linear PEG polymers ( Figure   S4 ).
In the case of sdFv-conjugated scPEG µgels, fibrin-particle interactions become net attractive due to the presence of covalently bound sdFvs which specifically and strongly bind to fibrin fibers reversing the salting out effect of PEG. Thus, the interactions between PEG-PLPs and fibrin are thermodynamically favorable, which is suggested by the enhanced fiber density at areas with increased particle concentration.
Furthermore, the addition of non-binding S11-scPEG µgels influences the fibrin network neither in a positive or negative way, with these particles acting only as space filling material. These findings show that these constructs have the potential to act as
platelet-substitutes, since the fluid flow (i.e., blood) through fibrin gels is greatly diminished, possibly leading to reduced blood loss and bleeding times.
Fibrin clot degradation and protein transport
Lastly, we tested the ability of PEG-PLPs to increase the stability of fibrin clots against fibrinolysis. Pre-formed fibrin clots were subjected to exogenous degradation with plasmin using the setup established to characterize network permeability; fibrin gels were connected to a reservoir filled with a solution of plasmin and the flow rate through the gels was monitored at a constant pressure gradient as function of time. As is clear from Figure 5a It is important to note that fibrin gels polymerized in presence of S11-scPEG µgels exhibit degradation rates comparable to the fibrin control. This observation suggests that microgel particles partially occupying the voids in the fibrin network do not To test our first hypothesis, we investigated the permeability of PEG-PLP/fibrin assemblies for proteins with varying molecular weights and sizes. For this experiment, we selected 4 proteins: cytochrome c (Mw = 12 300 g/mol, r = 1.8 nm) [35] , AlexaFluor 594 labeled immunoglobulin IgG (Mw = 150 00 g/mol, r = 5.3 nm) [36] , β-Dglucosidase (Mw = 135 000 g/mol, radius n. d.) [37] , and AlexaFluor 488 fibrinogen (Mw = 340 000 g/mol, r = 10.7 nm) [38, 39] These proteins have Stokes radii that are smaller or larger than that of plasminogen A/B (inactive precursor of plasmin; Mw = 92 000/90 000 g/mol, Stokes radii = 4.3/4.5 nm [40] ). Figure 6 shows fibrinogen in the solution. [41, 42] Nonetheless, these experiments demonstrate that PEG-PLP/fibrin composites and control clots have comparable permeability for small biomolecules, suggesting that plasmin is able to freely diffuse through the fibrin network in presence of PEG-PLPs resulting in uniform degradation throughout the clot. Consequently, these findings strongly support our second hypothesis: free diffusion of small biomolecules, such as plasmin, is not impaired; however, PEG-PLPs strongly interact with fibrin and stabilize the fibrin network against plasmin-induced degradation by forming additional physical cross-links between fibrin fibers and by enhancing the fibrin network density.
Additionally, transport of fibrin fragments out of the degrading clot is likely hindered by the presence of dense fibrin regions. This likely retards the hydrolysis of the fibrin network by plasmin. This is an important outcome since it suggests that PEG-PLPs could stabilize the fibrin clot in hemostasis and the early stages of the wound healing process without effecting the transport of important (bio)molecules through the clot.
Conclusions
The ultimate goal of this work was to design PLPs from soft colloidal particles and to analyze their effect on the morphological and (bio)physical properties of the fibrin clot in vitro. Self-cross-linked, PEG-side-chain microgels were rendered fibrin specific through chemoligation to sdFvs having fibrin binding constants in the nM range. [43] Strong adhesion between PEG-PLPs and fibrin results in the formation of dense fibrin regions distributed across the whole fibrin clot. The experimental data suggest fibrin- fibrin clot in vivo without the use of antifibrinolytic therapies. [27, 44] Moreover, we found that fluid flow through fibrin clots formed in presence of either PEG-PLPs or particles carrying non-specific antibody fragments, S11-scPEG µgels, is greatly diminished. From these findings we conclude that the reduced permeability is the consequence of the particles acting as space fillers for the voids in the fibrin network.
The locally enhanced fibrin structures observed for gels formed in presence of PEG-PLPs only has a minor contribution. Althoughthe reinforcement of the fibrin clot by fibrin-specific PEG-PLPs delays clot degradation by plasmin, it does not limit the diffusion of biomolecules throughout the fibrin clot. This finding is very important with regards to the transport of crucial molecules participating in wound healing. In summary, this study highlights the platelet-mimetic activity of PEG-PLPs and the potential use of these systems as synthetic hemostats with application in emergency medicine. 
